false
Catalog
Strategic Planning for Opioid Settlement Spending- ...
Part 2
Part 2
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation focused on handling settlement funds related to opioid crises, emphasizing informed financial strategies even amidst sensitive issues involving human lives. It highlighted the importance of maximizing the impact of limited funds to save as many lives as possible, underscoring cost-benefit analyses in decision-making. The data presented marked a noticeable rise in fatal opioid overdoses, primarily from fentanyl, after 2019 with some recent slight declines attributed to potentially less potent substances and effective prevention efforts. The discussion also drew attention to demographic differences in overdose rates, emphasizing the rise in overdoses among racial and ethnic minorities. The significant increase in opioid-related fatalities and emergency department visits underscored the ongoing crisis. Additionally, youth substance use was notably higher post-2020 across Oregon. The session directed focus on strategic investment in evidence-based treatments and prevention strategies, advocating for impactful and prioritized spending of settlement funds to address both opioid use disorder and related mental health issues. Collaborative community efforts were encouraged, with considerations for city and county-wide resource prioritization to effectively tackle this complex challenge. The discussion also covered various overdose handling resources like sobering centers and detox services, essential but varied in application and accessibility.
Keywords
opioid crisis
settlement funds
fentanyl overdoses
demographic differences
prevention strategies
evidence-based treatments
community collaboration
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English